News Articles on ev3 Inc.

Video: ev3 Inc. Announces First Patient Enrollments in DEFINITIVE LE Post-Market Study

Largest Study to Date Will Evaluate SilverHawk Plaque Excision System for Treatment of Lower Extremity Peripheral Arterial Disease

http://www.bioportfolio.com/news/Video%3A_ev3_Inc._Announces_First_Patient.html - Thursday April 30 2009

ev3 Inc. Reports 2008 Fourth Quarter and Full-Year Financial Results and 2009 Guidance

ev3 Inc. to Report 2008 Fourth Quarter and Full-Year Financial Results and Host Conference Call on February 24, 2009

PLYMOUTH, Minn., Feb. 6 /PRNewswire-FirstCall/ -- ev3 Inc. (Nasdaq: EVVV) will release its 2008 fourth quarter and full-year financial results and
http://www.bioportfolio.com/news/ev3_Inc._to_Report_2008_Fourth_Quarter_and.html - Friday February 6 2009

ev3 Inc. Appoints Shawn McCormick as New Sr. Vice President and Chief Financial Officer

PLYMOUTH, Minn., Jan. 9 /PRNewswire-FirstCall/ -- ev3 Inc. (Nasdaq: EVVV), a global endovascular device company, today announced the appointmen
http://www.bioportfolio.com/news/ev3_Inc._Appoints_Shawn_McCormick_as_New_Sr._Vice.html - Friday January 9 2009

ev3 Inc. to Present at the 27th Annual J.P. Morgan Healthcare Conference

PLYMOUTH, Minn., Jan. 5 /PRNewswire-FirstCall/ -- ev3 Inc. (Nasdaq: EVVV) today announced that Robert Palmisano, president and chief executive offi
http://www.bioportfolio.com/news/ev3_Inc._to_Present_at_the_27th_Annual_J.P..html - Monday January 5 2009

ev3 Inc. Appoints John L. Miclot to Board of Directors

PLYMOUTH, Minn., Dec. 3 /PRNewswire-FirstCall/ -- ev3 Inc. (Nasdaq: EVVV), a global endovascular device company, today announced the appointmen
http://www.bioportfolio.com/news/ev3_Inc._Appoints_John_L._Miclot_to_Board_of.html - Wednesday December 3 2008

ev3 Inc. Reports Third Quarter 2008 Financial Results

PLYMOUTH, Minn., Oct. 31 /PRNewswire-FirstCall/ -- ev3 Inc. (Nasdaq: EVVV), a global endovascular device company, today reported financial resu
http://www.bioportfolio.com/news/ev3_Inc._Reports_Third_Quarter_2008_Financial.html - Friday October 31 2008

ev3 Inc. to Report 2008 Third Quarter Financial Results and Host Conference Call on October 31, 2008

PLYMOUTH, Minn., Oct. 24 /PRNewswire-FirstCall/ -- ev3 Inc. (Nasdaq: EVVV) will release its 2008 third quarter and year-to-date financial resul
http://www.bioportfolio.com/news/ev3_Inc._to_Report_2008_Third_Quarter_Financial.html - Friday October 24 2008

ev3 Inc. to Present at the 2008 UBS Global Life Sciences Conference

PLYMOUTH, Minn., Sept. 11 /PRNewswire-FirstCall/ -- ev3 Inc. (Nasdaq: EVVV) today announced that Pat Spangler, chief financial officer, and Jul
http://www.bioportfolio.com/news/ev3_Inc._to_Present_at_the_2008_UBS_Global_Life.html - Thursday September 11 2008

ev3 Inc. Appoints Douglas W. Kohrs to Board of Directors

PLYMOUTH, Minn., Aug. 4 /PRNewswire-FirstCall/ -- ev3 Inc. (Nasdaq: EVVV), a global endovascular device company, today announced the appointmen
http://www.bioportfolio.com/news/ev3_Inc._Appoints_Douglas_W._Kohrs_to_Board_of.html - Monday August 4 2008

ev3 Inc. to Present at the Noble Financial Equity Conference

PLYMOUTH, Minn., Aug. 4 /PRNewswire-FirstCall/ -- ev3 Inc. (Nasdaq: EVVV) today announced that Pat Spangler, chief financial officer, and Julie
http://www.bioportfolio.com/news/ev3_Inc._to_Present_at_the_Noble_Financial_Equity.html - Monday August 4 2008

ev3 Inc. to Present at the Canaccord Adams 28th Annual Global Growth Conference

PLYMOUTH, Minn., July 31 /PRNewswire-FirstCall/ -- ev3 Inc. (Nasdaq: EVVV) today announced that Pat Spangler, chief financial officer, and Juli
http://www.bioportfolio.com/news/ev3_Inc._to_Present_at_the_Canaccord_Adams_28th.html - Thursday July 31 2008

ev3 Inc. Reports Second Quarter 2008 Financial Results

PLYMOUTH, Minn., July 28 /PRNewswire-FirstCall/ -- ev3 Inc. (Nasdaq: EVVV), a global endovascular device company, today reported financial resu
http://www.bioportfolio.com/news/ev3_Inc._Reports_Second_Quarter_2008_Financial.html - Monday July 28 2008

ev3 Inc. Announces Revised Date for 2008 Second Quarter Financial Results and Conference Call

PLYMOUTH, Minn., July 24 /PRNewswire-FirstCall/ -- ev3 Inc. (Nasdaq: EVVV) today announced a revised date to report its 2008 second quarter and
http://www.bioportfolio.com/news/ev3_Inc._Announces_Revised_Date_for_2008_Second.html - Thursday July 24 2008

ev3 Inc. Announces Promotion of Pascal E.R. Girin to Lead Global Neurovascular Business and International

PLYMOUTH, Minn., July 21 /PRNewswire-FirstCall/ -- ev3 Inc. (Nasdaq: EVVV) today announced that effective July 18, 2008, Pascal E.R. Girin was
http://www.bioportfolio.com/news/ev3_Inc._Announces_Promotion_of_Pascal_E.R._Girin.html - Monday July 21 2008

ev3 Inc. to Report 2008 Second Quarter Financial Results and Host Conference Call on August 1, 2008

PLYMOUTH, Minn., July 18 /PRNewswire-FirstCall/ -- ev3 Inc. (Nasdaq: EVVV) will release its 2008 second quarter and year-to-date financial resu
http://www.bioportfolio.com/news/ev3_Inc._to_Report_2008_Second_Quarter_Financial.html - Friday July 18 2008